Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
The first thing we need to do is agree on a definition of the word “cure.” Conventional oncology defines a cancer cure if the patient lives five years from diagnosis. I define a cancer cure as not dying of the cancer or health problems resulting from the cancer. Since I have lived well-beyond my diagnosis of multiple myeloma, conventional oncology considers me to be cured of my multiple myeloma.
I don’t consider myself cured of my myeloma. I will consider myself cured if I die of a different disease or of old age years from now.
Do myeloma patients have unrealistic expectations about their future? If they are told that a transplant is “curative” then yes, patients may develop the expectation that they will be cured of their multiple myeloma.
The article linked and excerpted below states that an autologous stem cell “transplant remains to be a curative and reliable strategy…” Yet according to the American Cancer Society, the average life expectancy for MM’s, based on your stage at diagnosis, is 3-5 years. To put it another way, the five-year survival rate for multiple myeloma is 47%.
If I hadn’t been young and “unrealistic” I probably would not have researched and undergone the non-conventional therapies that have kept me alive all these years. Despite the survival statistics I have lived in complete remission from my incurable cancer since 1999.
If you or a loved one have been diagnosed with Multiple Myeloma, let me say this loud and clear:
It is critical that you become an active participant in your care. Learn everything you can.
I am alive today largely because I took the time to find out everything I could about Multiple Myeloma and sought out the full spectrum of evidence-based MM therapies both conventional (FDA approved) and non-conventional.
Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.
Your decision-making begins by learning about the full spectrum of evidence-based myeloma therapies, both conventional and non-conventional. Here are some questions you may have right now:
I wish you all the best on your Multiple Myeloma journey.
“In the United States, multiple myeloma (myeloma, plasma cell myeloma) is the third most common hematologic malignancy after lymphoma and leukemia but the 14th most common malignancy overall.
This cancer affects plasma cells—frequently involving multiple sites, typically within the bone marrow—which demonstrate aberrant secretion of monoclonal antibodies.[3,4] Thus, myeloma is characterized by neoplastic proliferation of plasma cells in the bone marrow.
Myeloma is considered treatable but rarely curable with current treatment approaches.[3,5] Evidence exists that the bone marrow microenvironment of tumor cells may play a pivotal role in the pathogenesis of myeloma,[4,6] thus allowing for the expansion of treatment options.…
“But even with the FDA approvals of new agents for multiple myeloma and select lymphomas, transplant remains to be a curative and reliable strategy…”